Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model

Fig. 5

Suppression of CRC cells tumor angiogenesis by anti-VEGF and anti-EGFR antibodies. a Representative photographs of anti-CD34 staining in SW620 cells tumors. b The numbers of positively CD34 stained cells in subcutaneous SW620 and LoVo cells tumors. The data are representative of at least three different experiments ± SEM. *P < 0.05

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us